Table 1.
Comparison of changes in sphingolipid composition by patient population
| Patient Population | Source | Cer (%) | SM (%) | S1P (%) |
|---|---|---|---|---|
| DE Symptoms109 vs No DE Symptoms | Meibum | Increased | Increased | Not studied |
| Blepharitis + ATD vs Blepharitis118 | Meibum | Not studied | Decreased | Not studied |
| Blepharitis + ATD vs Controls118 | Meibum | Not studied | Decreased | Not studied |
| MGD: Individuals with poor quality meibum vs good quality meibum26 | Meibum | Decreased | Increased | Decreased |
| MGD: Individuals with poor quality meibum vs good quality meibum129 | Meibum | Decreased* | Increased | Not studied |
| MGD: Individuals with poor quality meibum vs good quality meibum129 | Tears | Increased* | Increased* | Not studied |
DE, dry eye; ATD, aqueous tear deficiency; MGD, meibomian gland dysfunction; Cer, ceramide; SM, sphingomyelin; S1P, sphingosine 1-phosphate
Difference was not statistically significant